ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F19%3A00113707" target="_blank" >RIV/00216224:14310/19:00113707 - isvavai.cz</a>
Result on the web
<a href="https://journals.lww.com/jhypertension/Abstract/2019/07001/ADHERENCE_TO_ANTIHYPERTENSIVE_MEDICATION_AND_LEFT.920.aspx" target="_blank" >https://journals.lww.com/jhypertension/Abstract/2019/07001/ADHERENCE_TO_ANTIHYPERTENSIVE_MEDICATION_AND_LEFT.920.aspx</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/01.hjh.0000573932.16624.68" target="_blank" >10.1097/01.hjh.0000573932.16624.68</a>
Alternative languages
Result language
angličtina
Original language name
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION
Original language description
According to current registry data, 37% of hypertensive patients reach target blood pressure level. The failure to achieve target blood pressure level cause cardiovascular complications and mortality. Poorly treated arterial hypertension is long-term asymptomatic condition leading to hypertension-mediated organ damage (HMOD), that can be detected by imaging methods and laboratory tests. The aim of our study was to find out the difference in left ventricular (LV) mass values in nonadherent and adherent hypertensive patients.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů